EDBI is a premier Asian investor with headquarters in Singapore.
EDBI's investments include SWAT, M-DAQ, Cityneon, Nuvation Bio, Structo, Inari, Biofourmis, ShopBack, CXA Group, Moka, Ambiq Micro and OakNorth.
Their exited investments include Livongo, LogRhythm, Moderna Therapeutics, Smaato, Knewton, Hedvig, Revance Therapeutics, Mblox, goBalto, Appcelerator, Fluidigm, Declara and Addex Therapeutics.